Novel approaches for TB vaccine and treatments : improving BCG vaccine and identification of a potential new drug target
Current strategies of TB control include vaccination as a preventive approach and drug-based treatment as post-exposure therapy. In my PhD studies, I aimed to contribute in both directions: improving the current BCG vaccine and identifying and characterizing novel TB drug targets. I developed a nove...
Main Author: | Liao, Ting Yu Angela |
---|---|
Language: | English |
Published: |
University of British Columbia
2016
|
Online Access: | http://hdl.handle.net/2429/59110 |
Similar Items
-
BCG vaccination following latent TB treatment: Possible implications for different settings
by: L. Goscé, et al.
Published: (2019-03-01) -
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
by: Michel de Jesús Aceves-Sánchez, et al.
Published: (2021-06-01) -
Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
by: Kathryn T Whelan, et al.
Published: (2009-06-01) -
Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population.
by: Chin-Hui Yang, et al.
Published: (2013-01-01) -
Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
by: Kathryn T. Whelan, et al.
Published: (2011-01-01)